Goldman Sachs: Buy, Sell, or Hold in 2026?

Goldman Sachs has outperformed recently—shares are up ~232% over five years and ~51% over the past year—driven by a rebound in M&A and IPO activity in 2025 and optimism for 2026 amid rumored large listings (e.g., OpenAI, SpaceX). Management has improved capital efficiency by exiting a consumer-lending push and selling on‑balance-sheet alternative investments (private equity, real estate), while the stock now trades at elevated valuations on price-to-tangible-book and forward P/E metrics. CEO David Solomon also flagged exploration of prediction markets as a potential new initiative; the author recommends existing holders can continue to hold but refrains from a fresh buy call due to valuation, suggesting accumulation on dips.

Analysis

Market structure: A pickup in M&A and IPO activity is a clear net positive for bulge‑bracket advisory and sales & trading desks — primaries: GS, MS, and exchanges (NDAQ, ICE). Goldman’s franchise, capital efficiency gains from selling on‑balance private assets, and large trading platform give it disproportionate share; expect advisory/underwriting fee pools to grow materially over the next 6–12 months as deal flow returns, lifting revenue volatility but improving ROE if rates stay benign.

Risk assessment: Key tail risks are (1) postponement/valuation collapse of marquee IPOs (OpenAI/SpaceX) within 1–6 months, (2) a regulatory reversal or targeted enforcement against large bank dealmaking over 3–12 months, and (3) a resurgence in rates that compresses multiples and trading flows. Hidden dependencies include GS’s reliance on mark‑to‑market trading and realized gains from asset disposals; these can swing capital ratios quickly in a stress window of days–weeks.

Trade implications: Tactical entry: stagger a 2–3% portfolio long in GS over the next 3 months, adding at a 10% and 20% drawdown; hedge with a 6–9 month GS call spread (buy nearer‑ATM, sell 25–30% OTM) to cap cost. Relative trade: long GS / short MS (1:1 dollar) for 3–9 months to express franchise outperformance. If income‑oriented, sell 3‑month GS puts ~10% OTM in size equal to targeted buy‑up to collect premium.

Contrarian angles: Consensus assumes a smooth IPO boom — that may be underdone given concentration risk (a few mega IPOs). Valuation is rich: set rules (take profits if GS rallies >15% from today or if P/TBV moves >10% above historical peers). Watch for unintended effects of asset sales: lower recurring fee streams could reduce long‑term earnings power despite near‑term capital relief.

Key Decisions for Investors

• Establish a staggered 2–3% long position in GS over 0–3 months: initial 1% now, add 1% at a 10% pullback and remaining 1% at a 20% pullback; target hold 6–12 months subject to catalyst outcomes (IPO announcements or Fed guidance).
• Buy a 6–9 month GS call spread (long nearer‑ATM call, short 25–30% OTM call) sized to cap downside to the premium — expresses upside to M&A/IPOs with defined risk; roll or close on a >15% GS rally or after major IPO pricing events.
• Execute a relative value pair: long GS / short MS (dollar‑neutral) for 3–9 months to capture franchise execution differences; unwind if MS outperforms by >8% or if sector implied volatility spikes >30% from baseline.
• Sell 3‑month GS puts ~10% OTM to generate yield equal to ~target purchase price if assigned; limit allocation to no more than intended buy size and close if implied vol rises >40% or if major IPOs are delayed beyond 90 days.
• Reduce weight in consumer/retail banking exposures by 1–2% (reallocate to Capital Markets/exchanges) ahead of expected rotational flows; monitor SEC/DOJ regulatory notices over next 30–60 days as a binary risk trigger for rebalancing.